Path: not-for-mail
From: Geo <Geo@invalid.pasdepub>
Newsgroups: fr.misc.actualite.covid19
Subject: Re: =?ISO-8859-15?Q?[Source_=3F]_Interactions_entre_le_Doliprane,?= =?ISO-8859-15?Q?_Efferalgan,_ni_Dafalgan_:_non_=E9tudi=E9?=
Date: Tue, 03 Oct 2023 14:51:38 +0200
Organization: A noiseless patient Spider
Lines: 12
Message-Id: <mn.1b7b7e7a80259689.119180@invalid.pasdepub>
References: <ufehg6$2vf10$1@dont-email.me> <NdkFLWpmGrmRWFS9SzwSKw6mfZg@jntp> <ufekq1$j3$1@rasp.pasdenom.info> <zqk1hBUOzsqZJdwxtIJg5d8BgDY@jntp> <ufemc4$3mn$1@rasp.pasdenom.info> <rV1LjWqatMnFnA9g3bQvutM99uM@jntp> <ufeni5$601$1@rasp.pasdenom.info> <uff07n$329sb$1@dont-email.me> <ufh0ti$6tv$1@rasp.pasdenom.info>
Mime-Version: 1.0
Content-Type: text/plain; charset="iso-8859-15"; format=flowed
Content-Transfer-Encoding: 8bit
Injection-Info: dont-email.me; posting-host="8cb074af0f515291f28ac12fb3bdacdd"; logging-data="3749166"; mail-complaints-to="abuse@eternal-september.org";	posting-account="U2FsdGVkX1+eWf/cVnF0sxP2MiZlzzuS"
Cancel-Lock: sha1:gPqhujPCXxOC9+Ij27AA8KpsSaw=
X-Face: 7Npr]YtaiRF.daNb$#]VN~Ph+$EZ@Vqao9W^*/2QgAYbsUU<]PPY}sIP@pph?LD;`I?poD7 =nir>(V(e{!5$QoRr;:&-"u3~RY><)
X-Newsreader: MesNews/1.08.06.00

De "Benoît L.", le 03/10/2023 :

>
> NEWS : DANGER DU PARACETAMOL
> Il s'avère que ni Doliprane, ni Efferalgan, ni Dafalgan n'ont fait des
> tests de compatibilité entre eux !

mdr

Vous croyez que ça va décourager Aubrin de continuer à débiter ses 
théories ?
M'étonnerait.